Anxiety on the First Day of Chemotherapy
The Effect of Art Design in the Chemotherapy Waiting Room on the Anxiety of Patients Who Will Receive Chemotherapy for the First Time
1 other identifier
interventional
106
1 country
1
Brief Summary
investigating chemotherapy anxieties
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable breast-cancer
Started Nov 2020
Shorter than P25 for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2020
CompletedFirst Submitted
Initial submission to the registry
April 7, 2021
CompletedFirst Posted
Study publicly available on registry
April 9, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 3, 2022
CompletedApril 9, 2021
April 1, 2021
10 months
April 7, 2021
April 7, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
anxiety and stress measurements
The State-Trait Anxiety Inventory (STAI) - Measuring anxiety with the Hospital Anxiety and Depression Scale (HADS)
60-120 minutes
Study Arms (2)
standard waiting room
NO INTERVENTIONstandard chemoterapy waiting room
waiting room enriched with art objects
EXPERIMENTALwaiting room enriched with music, paintings and artificial plants
Interventions
waiting room enriched with music, paintings and artificial plants
Eligibility Criteria
You may qualify if:
- to receive chemotherapy for breast cancer for the first time
- give consent for the study
You may not qualify if:
- not approving to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tekirdağ Namık Kemal ÜNiversitesi
Tekirdağ, 59100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asoc. Prof.
Study Record Dates
First Submitted
April 7, 2021
First Posted
April 9, 2021
Study Start
November 1, 2020
Primary Completion
August 31, 2021
Study Completion
March 3, 2022
Last Updated
April 9, 2021
Record last verified: 2021-04